In a commentary, Drs. Deepti Behl and Carolyn Dresler highlight the tobacco industry’s recent efforts to influence healthcare providers under the guise of smoking cessation education. Read more
Drs. Joelle Fathi and Matt Evision say cytisine more than doubles the chance of cessation and its expanding accessibility heralds a new era in the management of tobacco dependency. Read more
The UK recently moved to ban smoking for individuals born after 2009 while the US delayed implementation of a ban on menthol cigarettes—again. Read more
The association recommends collecting data on tobacco use status to advance knowledge on the impacts of tobacco smoke in the context of cancer clinical trials. Read more
Carolyn Dresler, MD, MPA, and Chris Bostic, JD, say plans to reduce the prevalence and impact of lung cancer must address smoking if they are to succeed. Read more
In a Q&A with ILCN, new JTO Clinical and Research Reports Editor-in-Chief Dr. Emily Stone discusses her passion for tobacco control and the importance of open-access journals in elevating research globally. Read more
In a Q&A with ILCN, Dr. William K. Evans weighs in on vaping and flavored tobacco regulations as well as cessation and prevention efforts. Read more
In Part 2 of our series on non-traditional methods to help patients quit smoking, Dr. Deepti Behl says it is important for healthcare providers to encourage their patients to quit smoking using current best practices as well as any other safe modality the patient perceives as helpful. Read more
While the harmful effects of smoking are well known, the negative impacts of continued smoking after a cancer diagnosis are underappreciated. With Lung Cancer Awareness Month under way, the association aims to change that with its new statement on tobacco cessation. Read more
While evidence is mixed on the efficacy of some non-traditional methods, Dr. Deepti Behl says lung cancer physicians should be familiar with the options and support patients who are willing to try to stop smoking. Read more